Nasdaq: BBOT
BridgeBio Oncology Therapeutics insiders
The officers, directors and 10% owners of BridgeBio Oncology Therapeutics, Inc. who hold the most stock, valued at the live BBOT price.
$1.86
BBOT today +$55K (+3.05%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their BBOT stock
- $56K
- Market value
- $149M
- Held by ranked insiders
- <0.1%
Insiders by value of BBOT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | John P. Schmid | Insider | 30,000 | $56K | <0.1% | 11065th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for BridgeBio Oncology Therapeutics; see each profile for the filing.